| Literature DB >> 8421184 |
M Tyndall1, M Malisa, F A Plummer, J Ombetti, J O Ndinya-Achola, A R Ronald.
Abstract
Ceftriaxone in a dose of 250 mg given intramuscularly is currently recommended for the treatment of chancroid. Among 133 men in Nairobi, Kenya, with culture-proven chancroid, who were treated with ceftriaxone, treatment failed in 35%. Poor outcome was associated with human immunodeficiency virus type 1 seropositivity. Thus, treatment recommendations for chancroid should be reevaluated.Entities:
Mesh：
Substances：
Year: 1993 PMID： 8421184 DOI： 10.1093/infdis/167.2.469
Source DB: PubMed Journal: J Infect Dis ISSN： 0022-1899 Impact factor: 5.226